A carregar...
Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer Patients Following Radical Prostatectomy
Prostate cancer is the most common cancer among men. The prospective discrimination of aggressive and clinically insignificant tumors still poses a significant and, as yet, unsolved problem. PITX2 DNA methylation is a strong prognostic biomarker in prostate cancer. Recently, a diagnostic microarray...
Na minha lista:
Publicado no: | J Mol Diagn |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Investigative Pathology
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5707187/ https://ncbi.nlm.nih.gov/pubmed/23266319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2012.11.002 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|